CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,071,070
- in 6 filings, $11.0M under 10b5-1 plans
Net −$11,071,070. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-24 | Olwill Shane Chief Development Officer | Grant or award · Stock Option (Right to buy) | +249,080 | 249,080 | ||
| 2022-02-22 | Olwill Shane Chief Development Officer | Grant or award · Stock Option (Right to buy) | +215,819 | 215,819 | ||
| 2021-08-30 | Olwill Shane Chief Development Officer | Exercise or conversion | +38,400 | $1.52 | $58K | 43,038 |
| 2021-08-30 | Olwill Shane Chief Development Officer | Sale | −9,200 | $5.00 | $46K | 33,838 |
| 2021-08-30 | Olwill Shane Chief Development Officer | Sale | −29,200 | $5.15 | $150K | 4,638 |
| 2021-08-30 | Olwill Shane Chief Development Officer | Exercise or conversion · Stock Option (right to buy) | −38,400 | 61,600 |
Page 1 of 1 · 6 trades